Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Human Noggin Protein (E. coli), Research Grade

The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4) . By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. [provided by RefSeq, Jul 2008]

Product Specifications

Background

The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4) . By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. [provided by RefSeq, Jul 2008]

Specifications

This protein carries no "tag". The protein has a calculated MW of 23.2 kDa. The protein migrates as 25 kDa±3 kDa under reducing (R) condition, and 65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE)

Expression Region

Gln 28 - Cys 232

Target

Noggin

Conjugation

Unconjugated

Tag

Native

Stability

-20°C to -70°C for 24 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Endotoxin

0.01 EU per μg

Purity

95%

Format

Powder

Buffer

20 mM NaAc, pH4.5

Molecular Weight

23.2 kDa

Additionnal Information

Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments

Shipping Conditions

RT

Storage Conditions

-20°C

Package Size

500ug*2

Host or Source

E. coli

Species

Human

Protein ID

Q13253-1

Preservative

Trehalose

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)
MBS1402238-01 0.02 mg (E-Coli)

Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)

Ask
View Details
Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)
MBS1402238-02 0.02 mg (Yeast)

Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)

Ask
View Details
Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)
MBS1402238-03 0.1 mg (E-Coli)

Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)

Ask
View Details
Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)
MBS1402238-04 0.1 mg (Yeast)

Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)

Ask
View Details
Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)
MBS1402238-05 0.02 mg (Baculovirus)

Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)

Ask
View Details
Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)
MBS1402238-06 0.02 mg (Mammalian-Cell)

Recombinant Shigella sonnei Glycine--tRNA ligase alpha subunit (glyQ)

Ask
View Details